Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells.

Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, Manos PD, Datta S, Lander ES, Schlaeger TM, Daley GQ, Rinn JL.

Nat Genet. 2010 Dec;42(12):1113-7. doi: 10.1038/ng.710. Erratum in: Nat Genet. 2010 Dec;42(12): 3 p following 1117.

2.

Nuclear transcriptome profiling of induced pluripotent stem cells and embryonic stem cells identify non-coding loci resistant to reprogramming.

Fort A, Yamada D, Hashimoto K, Koseki H, Carninci P.

Cell Cycle. 2015;14(8):1148-55. doi: 10.4161/15384101.2014.988031.

3.

lincRNAs act in the circuitry controlling pluripotency and differentiation.

Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, Yang X, Amit I, Meissner A, Regev A, Rinn JL, Root DE, Lander ES.

Nature. 2011 Aug 28;477(7364):295-300. doi: 10.1038/nature10398.

4.

Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts.

Pomeroy JE, Hough SR, Davidson KC, Quaas AM, Rees JA, Pera MF.

Stem Cells Transl Med. 2016 Jul;5(7):870-82. doi: 10.5966/sctm.2015-0250.

PMID:
27160704
5.

Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential.

Ohnuki M, Tanabe K, Sutou K, Teramoto I, Sawamura Y, Narita M, Nakamura M, Tokunaga Y, Nakamura M, Watanabe A, Yamanaka S, Takahashi K.

Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12426-31. doi: 10.1073/pnas.1413299111.

6.

Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors.

El-Sayed AK, Zhang Z, Zhang L, Liu Z, Abbott LC, Zhang Y, Li B.

Int J Mol Sci. 2014 Nov 27;15(12):21840-64. doi: 10.3390/ijms151221840.

7.

The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming.

Mansour AA, Gafni O, Weinberger L, Zviran A, Ayyash M, Rais Y, Krupalnik V, Zerbib M, Amann-Zalcenstein D, Maza I, Geula S, Viukov S, Holtzman L, Pribluda A, Canaani E, Horn-Saban S, Amit I, Novershtern N, Hanna JH.

Nature. 2012 Aug 16;488(7411):409-13. doi: 10.1038/nature11272.

PMID:
22801502
8.

Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.

Qin H, Blaschke K, Wei G, Ohi Y, Blouin L, Qi Z, Yu J, Yeh RF, Hebrok M, Ramalho-Santos M.

Hum Mol Genet. 2012 May 1;21(9):2054-67. doi: 10.1093/hmg/dds023.

9.

Divergent reprogramming routes lead to alternative stem-cell states.

Tonge PD, Corso AJ, Monetti C, Hussein SM, Puri MC, Michael IP, Li M, Lee DS, Mar JC, Cloonan N, Wood DL, Gauthier ME, Korn O, Clancy JL, Preiss T, Grimmond SM, Shin JY, Seo JS, Wells CA, Rogers IM, Nagy A.

Nature. 2014 Dec 11;516(7530):192-7. doi: 10.1038/nature14047. Erratum in: Nature. 2015 Jul 30;523(7562):626.

PMID:
25503232
10.

Comparison of reprogramming genes in induced pluripotent stem cells and nuclear transfer cloned embryos.

Duan L, Wang Z, Shen J, Shan Z, Shen X, Wu Y, Sun R, Li T, Yuan R, Zhao Q, Bai G, Gu Y, Jin L, Lei L.

Stem Cell Rev. 2014 Aug;10(4):548-60. doi: 10.1007/s12015-014-9516-1.

PMID:
24828831
11.

Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells.

Sommer CA, Christodoulou C, Gianotti-Sommer A, Shen SS, Sailaja BS, Hezroni H, Spira A, Meshorer E, Kotton DN, Mostoslavsky G.

PLoS One. 2012;7(12):e51711. doi: 10.1371/journal.pone.0051711.

12.

An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency.

Jo J, Hwang S, Kim HJ, Hong S, Lee JE, Lee SG, Baek A, Han H, Lee JI, Lee I, Lee DR.

Nucleic Acids Res. 2016 Feb 18;44(3):1203-15. doi: 10.1093/nar/gkv1468.

13.

Analysis of protein-coding mutations in hiPSCs and their possible role during somatic cell reprogramming.

Ruiz S, Gore A, Li Z, Panopoulos AD, Montserrat N, Fung HL, Giorgetti A, Bilic J, Batchelder EM, Zaehres H, Schöler HR, Zhang K, Izpisua Belmonte JC.

Nat Commun. 2013;4:1382. doi: 10.1038/ncomms2381.

14.

Epigenetic memory in induced pluripotent stem cells.

Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ.

Nature. 2010 Sep 16;467(7313):285-90. doi: 10.1038/nature09342.

15.

A reprogrammable mouse strain from gene-targeted embryonic stem cells.

Stadtfeld M, Maherali N, Borkent M, Hochedlinger K.

Nat Methods. 2010 Jan;7(1):53-5. doi: 10.1038/nmeth.1409.

16.

Does transcription factor induced pluripotency accurately mimic embryo derived pluripotency?

Lowry WE.

Curr Opin Genet Dev. 2012 Oct;22(5):429-34. doi: 10.1016/j.gde.2012.07.003. Review.

17.

LincRNAs join the pluripotency alliance.

Ng JH, Ng HH.

Nat Genet. 2010 Dec;42(12):1035-6. doi: 10.1038/ng1210-1035. No abstract available.

PMID:
21102618
18.

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.

Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR.

Nature. 2011 Mar 3;471(7336):68-73. doi: 10.1038/nature09798. Erratum in: Nature. 2014 Oct 2;514(7520):126.

19.

Novel Markov model of induced pluripotency predicts gene expression changes in reprogramming.

Hu Z, Qian M, Zhang MQ.

BMC Syst Biol. 2011;5 Suppl 2:S8. doi: 10.1186/1752-0509-5-S2-S8.

20.

Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming.

Hu X, Zhang L, Mao SQ, Li Z, Chen J, Zhang RR, Wu HP, Gao J, Guo F, Liu W, Xu GF, Dai HQ, Shi YG, Li X, Hu B, Tang F, Pei D, Xu GL.

Cell Stem Cell. 2014 Apr 3;14(4):512-22. doi: 10.1016/j.stem.2014.01.001.

Items per page

Supplemental Content

Support Center